NYBC Ventures
Boston, Massachusettsnybcventures.com
Overview
NYBC Ventures is an early-stage life sciences investment fund dedicated to advancing innovations in blood and cellular therapies, and related technologies. The fund invests in therapeutics, devices, and cutting-edge technologies that address critical challenges in these fields. Its mission is to improve patient outcomes by supporting groundbreaking therapeutics, platforms, and collaborative efforts.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| City Therapeutics | Jun 2026 | Series B | Co-investor |
| Vitestro | Mar 2026 | Series B | Co-investor |
| Cellular Origins | Dec 2025 | Series A | Co-investor |
| Akadeum Life Sciences | Jun 2025 | Series C | Co-investor |
| Vittoria Biotherapeutics | Nov 2024 | Private Financing Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.